<DOC>
	<DOCNO>NCT02078492</DOCNO>
	<brief_summary>Hypothesis : Intravenous administration Ketorolac dose 10 mg effective treat severe acute pain patient present ED 15 mg 30 mg .</brief_summary>
	<brief_title>A Prospective Randomized Double-Blind Trial Comparing 3 Doses Intravenous Ketorolac Pain Management</brief_title>
	<detailed_description>Ketorolac tromethamine non-steroidal anti-inflammatory drug ( NSAID ) widely use Emergency Department ( ED ) treatment moderate-to-severe pain . Ketorolac available oral parenteral form possess significant analgesic potency . However , ketorolac provide advantage currently available analgesic use limited virtue `` analgesic ceiling '' dose 10mg well range severe side effect , gastrointestinal hemorrhage concerning.The concept analgesic ceiling dos beyond value ( 10mg ) provide additional analgesia contribute side effect . In spite , majority research conduct ketorolac ED recommendation Tintinalli 's Emergency Medicine Textbook advocate use three-to-six fold high dosage . Hypothesis : Intravenous administration Ketorolac dose 10 mg effective treat severe acute pain patient present ED 15 mg 30 mg .</detailed_description>
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Severe flank abdominal pain , severe musculoskeletal pain ( traumatic nontraumatic origin ) , headache , dental pain . Age &gt; 65 , Active Peptic Ulcer disease , Acute Gastrointestinal Hemorrhage , Known Hx Renal Hepatic insufficiency , Hx allergies NSAIDS .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>